MEDP – Medpace Holdings, Inc.
MEDP — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
6.14
Margin Of Safety %
-11
Put/Call OI Ratio
1.36
EPS Next Q Diff
-0.57
EPS Last/This Y
1.74
EPS This/Next Y
1.82
Price
508.98
Target Price
515.64
Analyst Recom
2.73
Performance Q
-13.34
Upside
-33.9%
Beta
1.41
Ticker: MEDP
20 items
«
‹
of 1
›
»
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-03-09 | MEDP | 478.73 | 1.85 | 0.13 | 2029 |
| 2026-03-10 | MEDP | 466.9 | 1.85 | 0.12 | 2023 |
| 2026-03-11 | MEDP | 477.63 | 1.81 | 2.14 | 2035 |
| 2026-03-12 | MEDP | 443.38 | 1.82 | 0.50 | 2045 |
| 2026-03-13 | MEDP | 443.85 | 1.82 | 1.09 | 2045 |
| 2026-03-17 | MEDP | 454.86 | 1.88 | 0.25 | 2138 |
| 2026-03-18 | MEDP | 454.39 | 1.87 | 999.99 | 2139 |
| 2026-03-19 | MEDP | 460.64 | 1.86 | 0.22 | 2133 |
| 2026-03-20 | MEDP | 452.56 | 1.84 | 1.23 | 2137 |
| 2026-03-23 | MEDP | 456.41 | 1.45 | 0.25 | 856 |
| 2026-03-24 | MEDP | 461.67 | 1.40 | 1.43 | 873 |
| 2026-03-25 | MEDP | 466.98 | 1.38 | 8.40 | 876 |
| 2026-03-26 | MEDP | 466.59 | 1.41 | 0.67 | 901 |
| 2026-03-27 | MEDP | 451.02 | 1.41 | 2.19 | 906 |
| 2026-03-30 | MEDP | 460.24 | 1.43 | 0.00 | 903 |
| 2026-03-31 | MEDP | 480.21 | 1.44 | 0.00 | 899 |
| 2026-04-01 | MEDP | 489.02 | 1.42 | 0.56 | 905 |
| 2026-04-02 | MEDP | 498.55 | 1.39 | 0.17 | 948 |
| 2026-04-06 | MEDP | 496.29 | 1.38 | 0.90 | 951 |
| 2026-04-07 | MEDP | 508.58 | 1.36 | 0.43 | 966 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
20 items
«
‹
Current Page1 of 1
›
»
20 items
«
‹
of 1
›
»
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-03-09 | MEDP | 478.25 | 9.1 | 55.9 | 17.37 |
| 2026-03-10 | MEDP | 467.14 | 9.2 | 31.6 | 17.37 |
| 2026-03-11 | MEDP | 477.63 | 9.2 | 59.3 | 17.37 |
| 2026-03-12 | MEDP | 443.61 | 9.2 | 2.9 | 17.37 |
| 2026-03-13 | MEDP | 450.58 | 9.2 | 54.7 | 17.37 |
| 2026-03-17 | MEDP | 455.16 | 9.2 | 47.6 | 17.37 |
| 2026-03-18 | MEDP | 455.17 | 9.2 | 44.8 | 17.37 |
| 2026-03-19 | MEDP | 460.64 | 9.2 | 60.4 | 17.37 |
| 2026-03-20 | MEDP | 452.51 | 9.2 | 41.0 | 17.37 |
| 2026-03-23 | MEDP | 457.11 | 9.2 | 58.2 | 17.37 |
| 2026-03-24 | MEDP | 461.71 | 9.2 | 58.5 | 17.37 |
| 2026-03-25 | MEDP | 466.83 | 9.2 | 60.1 | 17.37 |
| 2026-03-26 | MEDP | 466.73 | 9.2 | 52.0 | 17.37 |
| 2026-03-27 | MEDP | 451.20 | 9.2 | 32.1 | 17.37 |
| 2026-03-30 | MEDP | 460.46 | 9.2 | 64.5 | 17.37 |
| 2026-03-31 | MEDP | 480.47 | 9.2 | 79.1 | 17.37 |
| 2026-04-01 | MEDP | 489.25 | 9.2 | 63.2 | 17.37 |
| 2026-04-02 | MEDP | 498.38 | 9.2 | 63.3 | 17.37 |
| 2026-04-06 | MEDP | 496.05 | 9.2 | 52.0 | 17.39 |
| 2026-04-07 | MEDP | 508.98 | 9.2 | 70.6 | 17.39 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
20 items
«
‹
Current Page1 of 1
›
»
20 items
«
‹
of 1
›
»
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-03-09 | MEDP | -6.59 | -1.82 | 5.65 |
| 2026-03-10 | MEDP | -6.59 | -1.82 | 5.65 |
| 2026-03-11 | MEDP | -6.59 | -1.82 | 5.63 |
| 2026-03-12 | MEDP | -6.59 | -1.82 | 5.63 |
| 2026-03-13 | MEDP | -6.59 | -1.82 | 5.63 |
| 2026-03-17 | MEDP | -6.59 | -1.75 | 5.63 |
| 2026-03-18 | MEDP | -6.59 | -1.75 | 5.63 |
| 2026-03-19 | MEDP | -7.08 | -1.75 | 5.63 |
| 2026-03-20 | MEDP | -7.08 | -1.75 | 5.63 |
| 2026-03-23 | MEDP | -7.08 | -1.76 | 5.63 |
| 2026-03-24 | MEDP | -7.08 | -1.76 | 5.63 |
| 2026-03-25 | MEDP | -7.08 | -1.76 | 6.14 |
| 2026-03-26 | MEDP | -7.08 | -1.76 | 6.14 |
| 2026-03-27 | MEDP | -7.08 | -1.76 | 6.14 |
| 2026-03-30 | MEDP | -7.08 | -1.76 | 6.14 |
| 2026-03-31 | MEDP | -7.08 | -1.76 | 6.14 |
| 2026-04-01 | MEDP | -7.08 | -1.76 | 6.14 |
| 2026-04-02 | MEDP | -7.08 | -1.76 | 6.14 |
| 2026-04-06 | MEDP | -7.08 | -1.71 | 6.14 |
| 2026-04-07 | MEDP | -7.08 | -1.71 | 6.14 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
20 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
4.67
Avg. EPS Est. Current Quarter
4.01
Avg. EPS Est. Next Quarter
4.1
Insider Transactions
-7.08
Institutional Transactions
-1.71
Beta
1.41
Average Sales Estimate Current Quarter
697
Average Sales Estimate Next Quarter
701
Fair Value
452.5
Quality Score
78
Growth Score
99
Sentiment Score
73
Actual DrawDown %
19.1
Max Drawdown 5-Year %
-42.9
Target Price
515.64
P/E
33.25
Forward P/E
26.67
PEG
2.12
P/S
5.74
P/B
31.35
P/Free Cash Flow
21.3
EPS
15.29
Average EPS Est. Cur. Y
17.39
EPS Next Y. (Est.)
19.21
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
17.83
Relative Volume
0.95
Return on Equity vs Sector %
70.8
Return on Equity vs Industry %
87.5
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.01
EBIT Estimation
70.6
◆
MEDP
Healthcare
$508.52
📉
Swing / Pullback
Buy the dip on strong trends
WEAK
Trend
20/20
Pullback
6/25
Volume
7/15
Valuation
8/20
TP/AR
0/10
Options
1/10
RSI
64.6
Range 1M
99.7%
Sup Dist
6%
🚀
N/A
Momentum Growth
Ride accelerating trends
WEAK
Momentum
9/25
Growth
14/30
Estimates
5/20
Inst/Vol
2/15
Options
3/10
EPS Yr
12.3%
EPS NY
11.2%
52W%
68.6%
💎
Long-Term Value
Quality companies, undervalued
WEAK
🔴 SELL
-11.5% upside
Quality
20/30
Valuation
2/30
Growth
13/25
Stability
4/10
LT Trend
3/5
Upside
-11.5%
Quality
78
MoS
-11%
Click a card to see score breakdown
Full Analysis →
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 6200
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
MEDP
Latest News
—
Caricamento notizie per MEDP…
stock quote shares MEDP – Medpace Holdings, Inc. Stock Price stock today
news today MEDP – Medpace Holdings, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch MEDP – Medpace Holdings, Inc. yahoo finance google finance
stock history MEDP – Medpace Holdings, Inc. invest stock market
stock prices MEDP premarket after hours
ticker MEDP fair value insiders trading